Ackermans & Van Haaren NV (EBR:ACKB)
Belgium
· Delayed Price · Currency is EUR 202.00
+2.20 (1.10%)
Apr 1, 2025, 3:34 PM CET
Ackermans & Van Haaren NV Employees
Ackermans & Van Haaren NV had 24,384 employees as of December 31, 2024. The number of employees increased by 2,497 or 11.41% compared to the previous year.
Employees
24,384
Change (1Y)
2,497
Growth (1Y)
11.41%
Revenue / Employee
€247,840
Profits / Employee
€18,860
Market Cap
6.60B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| DEME Group NV | 5,682 |
| Umicore | 11,251 |
| Cenergy Holdings | 3,247 |
| NV Bekaert | 21,000 |
| Viohalco | 10,955 |
| Floridienne | 3,303 |
| Recticel | 1,255 |
| Jensen-Group NV | 2,059 |
Ackermans & Van Haaren NV News
- 26 days ago - Full Year 2024 Ackermans & Van Haaren NV Earnings P Transcript - GuruFocus
- 4 weeks ago - Ackermans & van Haaren grows net profit by 15% in 2024 to 460 million euros. - GlobeNewsWire
- 4 months ago - Ackermans & van Haaren Trading Update Q3 2024 - AvH is on track towards a net profit well above 400 million euros - GlobeNewsWire
- 4 months ago - Ackermans & van Haaren and the Delen family confirm their long-term partnership with updated shareholder arrangements in respect of Delen Private Bank and Bank J. Van Breda & Co - GlobeNewsWire
- 6 months ago - Ackermans & van Haaren invests an additional 5 million euros in Biotalys - GlobeNewsWire
- 7 months ago - Ackermans & van Haaren: Outstanding results in core participations result in a strong increase of AvH's net profit for 1H2024 to EUR 200 million (+17%) - GlobeNewsWire
- 8 months ago - Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company - GlobeNewsWire
- 11 months ago - Ackermans & van Haaren: the General Shareholders' Meeting approves all proposed resolutions by a large majority - GlobeNewsWire